Advagraf®, a once-daily prolonged release tacrolimus formulation, in kidney transplantation: literature review and guidelines from a panel of experts

Extended-Release Tacrolimus: A Review of Its Use in De Novo Kidney Transplantation

(2014) Paul L. McCormack   DRUGS

Comparison of Pharmacokinetics and Pathology for Low-Dose Tacrolimus Once-Daily and Twice-Daily in Living Kidney Transplantation

(2013) Tomohiro Tsuchiya et al.   TRANSPLANTATION

OSAKA Trial

(2013) Laetitia Albano et al.   TRANSPLANTATION

Long-term Follow-up of Stable Kidney Transplant Recipients After Conversion From Tacrolimus Twice Daily Immediate Release to Tacrolimus Once-daily Prolonged Release: A Large Single-Center Experience

(2013) J. Slatinska et al.   TRANSPLANTATION PROCEEDINGS

Tacrolimus Pharmacokinetics of Once- Versus Twice-Daily Formulations in De Novo Kidney Transplantation

(2012) Zbigniew Wlodarczyk et al.   THERAPEUTIC DRUG MONITORING

Improved Adherence to Tacrolimus Once-Daily Formulation in Renal Recipients

(2012) Dirk R.J. Kuypers et al.   TRANSPLANTATION

Efficacy and Safety of Conversion from Twice-daily to Once-daily Tacrolimus in a Large Cohort of Stable Kidney Transplant Recipients

(2011) L. Guirado et al.   AMERICAN JOURNAL OF TRANSPLANTATION

No change in insulin sensitivity in renal transplant recipients converted from standard to once-daily prolonged release tacrolimus

(2011) K. Midtvedt et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Lower Variability of Tacrolimus Trough Concentration After Conversion From Prograf to Advagraf in Stable Kidney Transplant Recipients

(2011) Ming-Ju Wu et al.   TRANSPLANTATION

Therapeutic Drug Monitoring in De Novo Kidney Transplant Receiving the Modified-Release Once-Daily Tacrolimus

(2011) M.L. Jelassi et al.   TRANSPLANTATION PROCEEDINGS

Improved Kidney Graft Function After Conversion From Twice Daily Tacrolimus to a Once Daily Prolonged-Release Formulation

(2011) A. Kolonko et al.   TRANSPLANTATION PROCEEDINGS

Tacrolimus Once Daily (ADVAGRAF) Versus Twice Daily (PROGRAF) in De Novo Renal Transplantation: A Randomized Phase III Study

(2010) B. K. Krämer et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Population pharmacokinetic model and Bayesian estimator for two tacrolimus formulations - twice daily Prograf® and once daily Advagraf®

(2010) Jean-Baptiste Woillard et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Population Pharmacokinetics and Bayesian Estimation of Tacrolimus Exposure in Renal Transplant Recipients on a New Once-Daily Formulation

(2010) Khaled Benkali et al.   CLINICAL PHARMACOKINETICS

Reduced C0 Concentrations and Increased Dose Requirements in Renal Allograft Recipients Converted to the Novel Once-Daily Tacrolimus Formulation

(2010) Hylke de Jonge et al.   TRANSPLANTATION

Extended-Release Tacrolimus Therapy in De Novo Kidney Transplant Recipients: Single-Center Experience

(2010) A. Andrés et al.   TRANSPLANTATION PROCEEDINGS

Improvement of Graft Function after Conversion to Once Daily Tacrolimus of Stable Kidney Transplant Patients

(2010) F. Tinti et al.   TRANSPLANTATION PROCEEDINGS

Pharmacokinetics for Once- Versus Twice-Daily Tacrolimus Formulations inDe NovoKidney Transplantation: A Randomized, Open-Label Trial

(2009) Z. Wlodarczyk et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Conversion to Tacrolimus Extended-Release Formulation: Short-term Clinical Results

(2009) E. Gallego-Valcarce et al.   TRANSPLANTATION PROCEEDINGS

De Novo Kidney Transplant Recipients Need Higher Doses of Advagraf Compared With Prograf to Get Therapeutic Levels

(2009) M. Crespo et al.   TRANSPLANTATION PROCEEDINGS